November 2020
Procore signs a Distribution agreement with a local Chinese company, in collaboration with the largest pharmaceutical distributor in China.
Procore signs a Distribution agreement with a local Chinese company, in collaboration with the largest pharmaceutical distributor in China. The company has committed to complete regulatory and CFDA guided trials within 18 months and begin distributing and selling RegenoGel in greater China in the second quarter of 2022.